Intriguingly, high ASAP2 levels could also predict poor prognosis across several types of malignancies, including cervical, lung, pancreatic, and uterine cancers (Additional file 1: Fig. S3A–D), suggesting that ASAP2 is a common contributor to cancer progression. This evidence concerns the gene ASAP2 and cancer.